# LCC-CARIS-01: Molecular Profiling in Gynaecological Cancer

> **NCT02668913** · NA · COMPLETED · sponsor: **Geoff Hall** · enrollment: 72 (actual)

## Conditions studied

- Epithelial Ovarian Cancer
- Peritoneal Cancer
- Fallopian Tube Cancer
- Gynaecological Malignancy

## Interventions

- **OTHER:** Diagnostic analysis

## Key facts

- **NCT ID:** NCT02668913
- **Lead sponsor:** Geoff Hall
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2018-10
- **Final completion:** 2020-10
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2024-05-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02668913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02668913, "LCC-CARIS-01: Molecular Profiling in Gynaecological Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02668913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*